TSS
KAPA

Two Sigma Securities’s Kairos Pharma KAPA Stock Holding History

Two Sigma Securities’s Portfolio KAPA Stock Details KAPA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.08K Buy
+16,247
New +$10.9K ﹤0.01% 1475
2025
Q4 		– Sell
-24,895
Closed -$29.1K – 2132
2025
Q3 		$29.1K Buy
24,895
+11,340
+84% +$13K ﹤0.01% 1070
2025
Q2 		$9.61K Buy
+13,555
New +$9.86K ﹤0.01% 1304

Other funds holding KAPA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
SFG
SevenBridge Financial Group Harrisburg, Pennsylvania $680M AUM 30.75% 1-Year Est. Return
ACA
Aptus Capital Advisors Fairhope, Alabama $14.6B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Two Sigma Securities's KAPA Position: Q1 2026 in Review

Two Sigma Securities opened a new position in Kairos Pharma (KAPA) in Q1 2026: 16,247 shares worth $9.08K. The stake represents ﹤0.01% of the portfolio and ranks #1475 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in KAPA as recently as Q3 2025.

Two Sigma Securities first reported a position in KAPA in Q2 2025 and has held it in 3 quarters since. The position peaked at $29.1K in Q3 2025. 11 funds tracked by Wall St. Rank hold KAPA as of Q1 2026.

  • Two Sigma Securities held 16,247 shares of Kairos Pharma worth $9.08K as of Q1 2026.
  • Kairos Pharma was a new Two Sigma Securities position in Q1 2026.
  • Kairos Pharma made up ﹤0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1475 holding.
  • Two Sigma Securities first reported a position in Kairos Pharma in Q2 2025 and has held it in 3 quarters since.
  • Two Sigma Securities's Kairos Pharma position peaked at $29.1K in Q3 2025.
  • 11 funds tracked by Wall St. Rank held Kairos Pharma as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.